Impurity Profiling Using Convergence Chromatography and Mass Spectrometry

Author(s)Michael D. Jones, Warren Potts

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling.

Coupling ultra-performance convergence chromatography to mass spectrometry provides an important tool for pharmaceutical analysis.

The authors describe the use of convergence chromatography combined with mass spectrometry for impurity profiling. This was achieved by using metoclopramide and its related substances and metoclopramide drug products as examples.

View

Pharmaceutical Technology’s 2013 Analytical and Bioanalytical Testing ebook

Articles in this issue

almost 13 years ago

Article

Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis

almost 13 years ago

Article

Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations

almost 13 years ago

Article

Identification and Quantification of Trace-Level Protein Impurities

almost 13 years ago

Article

Ultra-High-Speed Analysis of Ibuprofen Using HPLC

almost 13 years ago

Article

Characterization with Atomic Force Microscopy, Topographic, and 3D Raman

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.